Reviva Pharmaceuticals
RVPH
RVPH
15 hedge funds and large institutions have $4.68M invested in Reviva Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.31% less ownership
Funds ownership: 0.93% → 0.63% (-0.31%)
38% less capital invested
Capital invested by funds: $7.54M → $4.68M (-$2.87M)
Holders
15
Holding in Top 10
–
Calls
$230K
Puts
$25K
Top Buyers
| 1 | +$27.9K | |
| 2 | +$25.3K | |
| 3 | +$5.83K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$2.67K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.23K |
Top Sellers
| 1 | -$2.04M | |
| 2 | -$57.7K | |
| 3 | -$6.74K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6K |
| 5 |
BlackRock
New York
|
-$3.99K |